Enlarge image
Ampoule with the vaccine from the manufacturer Johnson & Johnson
Photo: Bernd Weissbrod / dpa
The corona vaccine from the manufacturer Johnson & Johnson is apparently threatened with a fate similar to that of AstraZeneca: According to information from SPIEGEL, the Standing Vaccination Commission (Stiko) only wants to recommend it for people aged 60 and over on Monday.
Younger people should be allowed to continue using the vaccine after being informed by a doctor.
The press office of the Robert Koch Institute confirmed that they expected a statement from Stiko on Monday.
A spokesman did not want to comment on what this would look like.
Similar to the vaccine from the British-Swedish manufacturer AstraZeneca, blood clots were also observed in individual cases at Johnson & Johnson after a vaccination.
The USA had therefore temporarily suspended vaccinations with the vaccine.
Ultimately, however, the FDA and the CDC jointly decided to use the active ingredient again.
Ema unreservedly recommends J&J vaccines
The Johnson & Johnson vaccine has been approved in the EU since March, but has rarely been administered there.
Because of the thrombosis cases in the USA, the manufacturer temporarily stopped the delivery planned for mid-April.
After an examination of the blood clot cases that occurred in the USA in connection with the vaccine, the EU Medicines Agency recently announced that it would adhere to its recommendation for the vaccine.
The EU authority based its decision on the fact that the benefits of the vaccine outweigh the risks.
However, blood clots should be included in the list of "very rare" side effects.
A warning can be added to the product information.
The Johnson & Johnson vector virus vaccine has the advantage of being easy to store.
In addition, only one dose is necessary for immunization.
It should therefore be used more in social hot spots in Germany.
The expected Stiko recommendation is likely to cause problems: Many older people in Germany have already been vaccinated with products from other manufacturers - the group of people for whom Johnson & Johnson is then recommended could therefore be very manageable.
